Chronic wasting disease pathogen mapped by Hamilton scientists could help create vaccine
Microscopic analysis by Montana scientists has revealed the first detailed structure of the pathogen that causes chronic ...
Business Insider2d
Sangamo Biosciences: Strategic Advancements and Collaborations Bolster Buy Rating
Additionally, the anticipated completion of a Phase 1/2 trial for its Fabry disease program within the first half of 2025, along with a potential Clinical Trial Application in prion disease ... and ...
Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported business highlights and third quarter 2024 financial results. "This is ...